Physician

Charles E Gambla, MD

According to 2025 Medicare claims, Charles Gambla, MD (NPI: 1275573107) practices dermatology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is ALABAMA DERMATOLOGY ASSOCIATES, PC (NPI: 1033128897; TIN: 63-0776876) and primary practice location at 35473-5204.

Gambla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 364 traditional Medicare patients, billed 2,675 HCPCS/CPT codes, and received $388,340 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 510 prescription claims across 223 beneficiaries totaling $5,972 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 47 records totaling $1,100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $735,251 to $388,340. Similarly, Part D prescription costs have fallen sharply in recent years, from $25,881 to $5,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$368K$735K2015 Medicare payment: $735,251 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $718,928 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $569,138 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $558,932 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $596,543 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $507,783 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $441,015 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $382,080 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $264,584 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $388,340 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1365,129$735,251
20161,0524,680$718,928
20177743,534$569,138
20186653,008$558,932
20196453,373$596,543
20205073,115$507,783
20214792,490$441,015
20224482,365$382,080
20233081,565$264,584
20243642,675$388,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2015 Drug cost: $25,881 (USD; Tot_Drug_Cst)2016 Drug cost: $18,713 (USD; Tot_Drug_Cst)2017 Drug cost: $16,794 (USD; Tot_Drug_Cst)2018 Drug cost: $16,747 (USD; Tot_Drug_Cst)2019 Drug cost: $15,190 (USD; Tot_Drug_Cst)2020 Drug cost: $14,047 (USD; Tot_Drug_Cst)2021 Drug cost: $13,393 (USD; Tot_Drug_Cst)2022 Drug cost: $10,820 (USD; Tot_Drug_Cst)2023 Drug cost: $5,423 (USD; Tot_Drug_Cst)2024 Drug cost: $5,972 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155101,226$25,881
20164581,049$18,713
2017458996$16,794
20184891,184$16,747
20194881,140$15,190
20204091,101$14,047
20214171,094$13,393
2022338787$10,820
2023163333$5,423
2024223510$5,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks205316$371
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm112137$165
11102Biopsy of related skin growth, first growth168228$58
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more158208$36
17000Destruction of precancer skin growth, 1 growth116137$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MupirocinMupirocin1452,961$1,060
Betamethasone DipropionateBetamethasone Dipropionate13371$796
CephalexinCephalexin1441,056$789
CiclopiroxCiclopirox Olamine20549$676
Triamcinolone AcetonideTriamcinolone Acetonide461,268$606

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.47$1,100ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles E. Gambla, MD?

Tedicare shows public-source Medicare data for Charles E. Gambla, MD (NPI 1275573107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles E. Gambla, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles E. Gambla, MD?

Charles E. Gambla, MD is linked to ALABAMA DERMATOLOGY ASSOCIATES, PC (billing NPI 1033128897) in the available physician profile data.

Does Charles E. Gambla, MD have Open Payments data?

Charles E. Gambla, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.